Nektar Therapeutics (LTS:0UNL)
$ 66 +4.33 (+7.02%) Market Cap: 2.21 Bil Enterprise Value: 1.72 Bil PE Ratio: 0 PB Ratio: 3.34 GF Score: 49/100

Nektar Therapeutics (LTS:0UNL) Transcripts

  • 1